The British journal of dermatology

publication venue for

The differing pathophysiologies that underlie COVID-19-associated perniosis and thrombotic retiform purpura: a case series. 2020
A case report of disappearing pigmented skin lesions associated with pembrolizumab treatment for metastatic melanoma. 2017
Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors. 2017
British Association of Dermatologists' guidelines for the safe and effective prescribing of methotrexate for skin disease 2016. 2016
Cutaneous involvement of disseminated adenovirus infection in an allogeneic stem cell transplant recipient. 2016
Steroid allergy in patients with inflammatory bowel disease. 2007
Multimodal in vivo optical imaging, including confocal microscopy, facilitates presurgical margin mapping for clinically complex lentigo maligna melanoma. 2005
Utility of the Wood's light: five cases from a pigmented lesion clinic. 2005
Follicular and epidermal alterations in patients treated with ZD1839 (Iressa), an inhibitor of the epidermal growth factor receptor. 2002
The Salford Psoriasis Index: an holistic measure of psoriasis severity. 2000
A case of necrotizing fasciitis due to Streptococcus pneumoniae. 1995
Hypocomplementaemic urticarial vasculitis, interstitial lung disease and hepatitis C. 1995
Cold urticaria and HIV infection. 1993
Ichthyosis, brittle hair, impaired intelligence, decreased fertility and short stature (IBIDS syndrome). 1982
Cholinergic urticaria with associated angio-oedema. 1981
Primary cutaneous aspergillosis in a premature neonate. 1980
Clinical research: photo validation study using Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI) scores in patients with dermatomyositis.. 188. 2023
Analysis of alopecia areata surveys suggests a threshold for improved patient-reported outcomes.. 187. 2022
Interleukin-17RA blockade by brodalumab decreases inflammatory pathways in hidradenitis suppurativa skin and serum.. 187. 2022
Bimekizumab for the treatment of moderate-to-severe plaque psoriasis: efficacy, safety, pharmacokinetics, pharmacodynamics and transcriptomics from a phase IIa, randomized, double-blind multicentre study.. 186. 2021
Standardized clinical photography considerations in patients across skin tones.. 186. 2021
Large-scale serum analysis identifies unique systemic biomarkers in psoriasis and hidradenitis suppurativa.. 186. 2021
Signalling of multiple interleukin (IL)-17 family cytokines via IL-17 receptor A drives psoriasis-related inflammatory pathways.. 185. 2021
Tralokinumab plus topical corticosteroids for the treatment of moderate-to-severe atopic dermatitis: results from the double-blind, randomized, multicentre, placebo-controlled phase III ECZTRA 3 trial.. 184. 2021
Doppler ultrasound-based noninvasive biomarkers in hidradenitis suppurativa: evaluation of analytical and clinical validity.. 184. 2020
Frontal fibrosing alopecia shows robust T helper 1 and Janus kinase 3 skewing.. 183. 2020
A risk prediction model for the development of subsequent primary melanoma in a population-based cohort.. 182. 2019
Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel.. 182. 2019
Development of a new patient-reported outcome measure to evaluate treatments for acne and acne scarring: the ACNE-Q.. 181. 2019
Inter-rater reliability of phenotypes and exploratory genotype-phenotype analysis in inherited hidradenitis suppurativa.. 181. 2019
FACE-Q Skin Cancer Module for measuring patient-reported outcomes following facial skin cancer surgery.. 179. 2018
Prevalence of alexithymia in patients with psoriasis and its association with disease burden: a multicentre observational study.. 176. 2017
Are patients capable and comfortable using mobile teledermoscopy?. 175. 2016
Integrating clinical information, dermoscopy and reflectance confocal microscopy to improve the diagnostic accuracy and confidence of amelanotic and lightly pigmented melanomas.. 175. 2016
A prospective phase III, randomized, double-blind, placebo-controlled study of brodalumab in patients with moderate-to-severe plaque psoriasis.. 175. 2016
Carbon dioxide laser ablation of basal cell carcinoma with visual guidance by reflectance confocal microscopy: a proof-of-principle pilot study.. 174. 2016
Multicentre study on inflammatory skin diseases from The International Confocal Working Group: specific confocal microscopy features and an algorithmic method of diagnosis.. 175. 2016
Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa.. 173. 2015
Cross-sectional analysis of the dermoscopic patterns and structures of melanocytic naevi on the back and legs of adolescents.. 173. 2015
Tildrakizumab (MK-3222), an anti-interleukin-23p19 monoclonal antibody, improves psoriasis in a phase IIb randomized placebo-controlled trial.. 173. 2015
A phase 2a randomized, double-blind, placebo-controlled, sequential dose-escalation study to evaluate the efficacy and safety of ASP015K, a novel Janus kinase inhibitor, in patients with moderate-to-severe psoriasis.. 173. 2015
Genetic factors associated with naevus count and dermoscopic patterns: preliminary results from the Study of Nevi in Children (SONIC).. 172. 2015
Elevated odds of metabolic syndrome in psoriasis: a population-based study of age and sex differences.. 172. 2014
Melanocytic naevi with globular and reticular dermoscopic patterns display distinct BRAF V600E expression profiles and histopathological patterns.. 171. 2014
Evaluating ex vivo fluorescence confocal microscopy images of basal cell carcinomas in Mohs excised tissue.. 171. 2014
Drug survival of fumaric acid esters for psoriasis: a retrospective study.. 171. 2014
Is universal screening for hepatitis C infection prior to commencing antitumour necrosis factor-α therapy necessary?. 169. 2013
Clinical and dermoscopic characteristics of new naevi in adults: results from a cohort study.. 169. 2013
Detection of skin cancer margins in Mohs excisions with high-speed strip mosaicing confocal microscopy: a feasibility study.. 169. 2013
Follicular cutaneous squamous cell carcinoma: an under-recognized neoplasm arising from hair appendage structures.. 169. 2013
Practical experience of ustekinumab in the treatment of psoriasis: experience from a multicentre, retrospective case cohort study across the U.K. and Ireland.. 166. 2012
Complete skin examination is essential in the assessment of dermatology patients: findings from 483 patients.. 165. 2011
Alcohol misuse in patients with psoriasis: identification and relationship to disease severity and psychological distress.. 164. 2011
Varicella-zoster virus immunity in dermatological patients on systemic immunosuppressant treatment.. 164. 2011
In vivo reflectance confocal microscopy of shave biopsy wounds: feasibility of intraoperative mapping of cancer margins.. 163. 2010
Clinical and genetic predictors of response to narrowband ultraviolet B for the treatment of chronic plaque psoriasis.. 163. 2010
Detection of basal cell carcinomas in Mohs excisions with fluorescence confocal mosaicing microscopy.. 160. 2009
Dermoscopic patterns and subclinical melanocytic nests in normal-appearing skin.. 160. 2009
Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways.. 159. 2008
Innervation and receptor profiles of the human apocrine (epitrichial) sweat gland: routes for intervention in bromhidrosis.. 159. 2008
Dermoscopic patterns of naevi in fifth grade children of the Framingham school system.. 158. 2008
Complex dermoscopic pattern: a potential risk marker for melanoma.. 158. 2008
Development and validation of the Dermatomyositis Skin Severity Index.. 158. 2007
Alcohol consumption and psychological distress in patients with psoriasis.. 158. 2007
The absence of apoeccrine glands in the human axilla has disease pathogenetic implications, including axillary hyperhidrosis.. 156. 2007
Response of the hypothalamic-pituitary-adrenal axis to psychological stress in patients with psoriasis.. 153. 2005
Gene expression profiles in psoriasis: analysis of impact of body site location and clinical severity.. 152. 2005
Replacement of routine liver biopsy by procollagen III aminopeptide for monitoring patients with psoriasis receiving long-term methotrexate: a multicentre audit and health economic analysis.. 152. 2005
Successful treatment of psoriasis improves psoriasis-specific but not more general aspects of patients' well-being.. 151. 2004
Psoriasis genomics: analysis of proinflammatory (type 1) gene expression in large plaque (Western) and small plaque (Asian) psoriasis vulgaris.. 150. 2004
Circulating natural killer cells in psoriasis.. 149. 2003
Downregulation and altered spatial pattern of caveolin-1 in chronic plaque psoriasis.. 147. 2002
A cognitive-behavioural symptom management programme as an adjunct in psoriasis therapy.. 146. 2002
Ultrastructure of the hyperhidrotic eccrine sweat gland.. 145. 2001
Cutaneous side-effects in cancer patients treated with the antiepidermal growth factor receptor antibody C225.. 144. 2001
Cytokine gene polymorphisms in psoriasis.. 144. 2001
Combination treatment with methotrexate and cyclosporin for severe recalcitrant psoriasis.. 141. 1999
Large increments in psoralen-ultraviolet A (PUVA) therapy are unsuitable for fair-skinned individuals with psoriasis.. 140. 1999
The use of antibody to C5b-9 in the subclassification of lupus erythematosus.. 134. 1996
Can optical coherence tomography improve the management of basal cell carcinoma? 2019
How best to manage acral naevi. 2015
The psych and inflammatory skin disease. 2012
The Keloid Area and Severity Index (KASI): an objective tool for the evaluation of keloids. 2022
Raising the bar for efficacy in hidradenitis suppurativa: a rationale for combination targeted therapies. 2022
Mycophenolate mofetil and methotrexate efficacy in dermatomyositis. 2022
Risk of nonacral cutaneous melanoma after the diagnosis of acral melanoma. 2022
Accuracy of commercially available smartphone applications for the detection of melanoma. 2022
To see or not to see: a cross-sectional study suggesting lack of bias towards authors in the peer-review process. 2021
Weekly administration of brodalumab in hidradenitis suppurativa: an open-label cohort study. 2020
Treatment of severe cutaneous adverse reaction with tocilizumab. 2020
Near total body vitiligo secondary to immunotherapy for metastatic melanoma. 2020
Association of IRF4 single-nucleotide polymorphism rs12203592 with melanoma-specific survival. 2020
Defining drug-free remission of skin disease in patients with plaque psoriasis. 2020
Interleukin 17C is elevated in lesional tissue of hidradenitis suppurativa. 2019
Patient-reported health not associated with keratinocyte carcinoma treatment choice in a Medicare cohort of older adults. 2019
Evaluating patients' perspectives on social media: the importance of clearly reporting data search, cleaning and processing. 2019
Sonic Hedgehog pathway inhibitors: from clinical trials to clinical practice. 2019
Understanding racial disparities in mycosis fungoides through international collaborative studies. 2019
The optimal regimen of brentuximab vedotin for CD30⁺ cutaneous lymphoma: are we there yet? 2017
Functional melanoma-risk variant IRF4 rs12203592 associated with Breslow thickness: a pooled international study of primary melanomas. 2017
Framingham risk assessment in hidradenitis suppurativa. 2017
Fatigue as a symptom in psoriasis and psoriatic arthritis: an observational study. 2017
Reply to 'A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients'. 2017
Towards three-dimensional temporal monitoring of naevi: a comparison of methodologies for assessing longitudinal changes in skin surface area around naevi. 2016
Diagnostic delay in hidradenitis suppurativa is a global problem. 2015
The risk of nail changes with taxane chemotherapy: a systematic review of the literature and meta-analysis. 2015
Video-mosaicing of reflectance confocal images for examination of extended areas of skin in vivo. 2014
Body mass index, waist circumference and HOMA-IR correlate with the Psoriasis Area and Severity Index in patients with psoriasis receiving phototherapy. 2014
Vitamin D status in hidradenitis suppurativa. 2014
Liraglutide in combination with acitretin for severe recalcitrant psoriasis. 2013
Mass spectrometry-based proteomic analysis of cutaneous cryoglobulinaemia in formalin-fixed tissues. 2013
Malignancies developing in obese patients with psoriasis while on antitumour necrosis factor-α therapies: a case series. 2012
Does HLA-G prevent tissue destruction in psoriasis? 2011
Primary varicella-zoster infection in patients on biologic therapies for psoriasis. 2010
Psoriasis: an opportunity to identify cardiovascular risk. 2009
The treatment of viral warts with topical cidofovir 1%: our experience of seven paediatric patients. 2008
Treatment of acrodermatitis continua of Hallopeau with adalimumab. 2008
The PRIDE (Papulopustules and/or paronychia, Regulatory abnormalities of hair growth, Itching, and Dryness due to Epidermal growth factor receptor inhibitors) syndrome. 2006
Successful treatment of recalcitrant acrodermatitis continua of Hallopeau with adalimumab and acitretin. 2005
Parvovirus B19 and systemic sclerosis. 2005
Successful treatment of a refractory verruca in a child with acute lymphoblastic leukaemia with topical cidofovir. 2005
The effect of topical tacrolimus on severe recalcitrant chronic discoid lupus erythematosus. 2002
The effect of treatment on serum levels of soluble intercellular adhesion molecules and tumour necrosis factor-receptor 1 in psoriasis. 2001
Pityriasis rubra pilaris treated with acitretin and narrow-band ultraviolet B (Re-TL-01). 2000
Treatment of lichen planus of the penis with photodynamic therapy. 1999
Abnormal liver function tests induced by dapsone in a patient with dermatitis herpetiformis and primary sclerosing cholangitis. 1999
Intolerance of isotretinoin in a patient with anhidrotic ectodermal dysplasia. 1999
Recalcitrant pyoderma gangrenosum treated with systemic tacrolimus. 1999
Combination low-dose cyclosporin (Neoral) and hydroxyurea for severe recalcitrant psoriasis. 1999
Mycophenolate mofetil for psoriasis. 1998
Maintenance treatment with cyclosporin in psoriasis. 1998
Treatment of PUVA itch with capsaicin. 1997
Urticarial vasculitis. 1996
Towards 'interpretable' artificial intelligence for dermatology.. 181. 2019
Beyond skin deep: taking bedside dermatology to the next level with noninvasive technologies.. 178. 2018
John Updike and psoriasis.. 165. 2011
Gluten and psoriasis.. 142. 2000
Increased expression of interleukin-17 pathway genes in nonlesional skin of moderate-to-severe psoriasis vulgaris. 2015
Lasers and light-based therapies in ethnic skin: treatment options and recommendations for Fitzpatrick skin types V and VI. 2013
The role of mitochondrial function and cellular bioenergetics in ageing and disease. 2013
Psoriasis: evolution of pathogenic concepts and new therapies through phases of translational research. 2007
Novel immune-based therapies for psoriasis. 2002
Psoriasis: the future. 2001
New concepts in the management of mycosis fungoides. 1974

VIVO Weill Cornell Medical College

The British journal of dermatology Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)